Crossmark

Identification of novel neuraminidase 1 modulators as potential therapeutics for Alzheimer’s disease using virtual screening and molecular dynamics simulations

Crossref DOI link: https://doi.org/10.1038/s41598-025-22955-7

Published Online: 2025-11-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alzarea, Sami I.
Funding

Funding for this research was provided by:

King Salman Center for Disability Research (KSRG-2024-340)
License Information

Text and Data Mining valid from 2025-11-14

Version of Record valid from 2025-11-14
More Information

Article History

Received: 18 February 2025

Accepted: 3 October 2025

First Online: 14 November 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below